Cargando…
Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541480/ https://www.ncbi.nlm.nih.gov/pubmed/28827965 http://dx.doi.org/10.4103/pr.pr_8_17 |
_version_ | 1783254815956008960 |
---|---|
author | Parasuraman, Subramani Zhen, Khor Ming Banik, Urmila Christapher, Parayil Varghese |
author_facet | Parasuraman, Subramani Zhen, Khor Ming Banik, Urmila Christapher, Parayil Varghese |
author_sort | Parasuraman, Subramani |
collection | PubMed |
description | OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200 mg/kg treated groups. Except the normal control group, all other animals were administered with olanzapine 4 mg/kg intraperitoneally to induce obesity. The drugs were administered once daily, per oral for 28 days. During the experiment, body weight changes and behavior alterations were monitored at regular intervals. At the end of the experiment, blood sample was collected from all the experimental animals for biochemical analysis. Part of the liver and kidney tissues was harvested from the sacrificed animals and preserved in neutral formalin for histopathological studies. RESULTS: Curcumin showed a significant reduction in olanzapine-induced body weight gain on the rats and improved the locomotor effects. The effect of curcumin on olanzapine-induced body weight gain is not comparable with that of betahistine. CONCLUSION: This study has shown metabolic alteration effect of curcumin on olanzapine, an antipsychotic drug, treated SD rats. SUMMARY: Olanzapine is an atypical antipsychotic drug used for the treatment of schizophrenia and bipolar disorder. Obesity is an adverse effect of olanzapine, and the present study was made an attempt to study the effect of curcumin on olanzapine-induced obesity in rats. In this present study, curcumin significantly reduced olanzapine-induced body weight gain in rats. Abbreviations Used: 5HT: 5-hydroxytryptamine, ALP: Alkaline phosphatase, ALT: Alanine transaminase, ANOVA: Analysis of variance, AST: Aspartate transaminase, CMC: Carboxymethyl cellulose, D: Dopamine, H and E: Hematoxylin and Eosin stain, H: Histamine, HDL-C: Highdensity lipoprotein cholesterol, IP: Intraperitoneal, MAO: Monoamine oxidase, NaOH: Sodium hydroxide, SD rats: Sprague Dawley rats, TCs: Total cholesterols, TG: Triglyceride. [Image: see text] |
format | Online Article Text |
id | pubmed-5541480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55414802017-08-21 Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats Parasuraman, Subramani Zhen, Khor Ming Banik, Urmila Christapher, Parayil Varghese Pharmacognosy Res Original Article OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200 mg/kg treated groups. Except the normal control group, all other animals were administered with olanzapine 4 mg/kg intraperitoneally to induce obesity. The drugs were administered once daily, per oral for 28 days. During the experiment, body weight changes and behavior alterations were monitored at regular intervals. At the end of the experiment, blood sample was collected from all the experimental animals for biochemical analysis. Part of the liver and kidney tissues was harvested from the sacrificed animals and preserved in neutral formalin for histopathological studies. RESULTS: Curcumin showed a significant reduction in olanzapine-induced body weight gain on the rats and improved the locomotor effects. The effect of curcumin on olanzapine-induced body weight gain is not comparable with that of betahistine. CONCLUSION: This study has shown metabolic alteration effect of curcumin on olanzapine, an antipsychotic drug, treated SD rats. SUMMARY: Olanzapine is an atypical antipsychotic drug used for the treatment of schizophrenia and bipolar disorder. Obesity is an adverse effect of olanzapine, and the present study was made an attempt to study the effect of curcumin on olanzapine-induced obesity in rats. In this present study, curcumin significantly reduced olanzapine-induced body weight gain in rats. Abbreviations Used: 5HT: 5-hydroxytryptamine, ALP: Alkaline phosphatase, ALT: Alanine transaminase, ANOVA: Analysis of variance, AST: Aspartate transaminase, CMC: Carboxymethyl cellulose, D: Dopamine, H and E: Hematoxylin and Eosin stain, H: Histamine, HDL-C: Highdensity lipoprotein cholesterol, IP: Intraperitoneal, MAO: Monoamine oxidase, NaOH: Sodium hydroxide, SD rats: Sprague Dawley rats, TCs: Total cholesterols, TG: Triglyceride. [Image: see text] Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5541480/ /pubmed/28827965 http://dx.doi.org/10.4103/pr.pr_8_17 Text en Copyright: © 2017 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Parasuraman, Subramani Zhen, Khor Ming Banik, Urmila Christapher, Parayil Varghese Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title | Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title_full | Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title_fullStr | Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title_full_unstemmed | Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title_short | Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats |
title_sort | ameliorative effect of curcumin on olanzapine-induced obesity in sprague-dawley rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541480/ https://www.ncbi.nlm.nih.gov/pubmed/28827965 http://dx.doi.org/10.4103/pr.pr_8_17 |
work_keys_str_mv | AT parasuramansubramani ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats AT zhenkhorming ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats AT banikurmila ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats AT christapherparayilvarghese ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats |